Search research articles
Contact Us
Filters
Showing results (11-20 of 24) with videos related to
Page
of 3
Sort By:
Osteoarthritis and Cartilage
|
June 6, 2024
Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?
Felix Eckstein, Anna Wisser, Susanne Maschek, et al.
Osteoarthritis and Cartilage
|
September 27, 2025
A single intra-articular injection of JTA-004, a combination of human plasma, hyaluronic acid, and clonidine, versus placebo in symptomatic knee osteoarthritis: A Phase 3 trial
Asger Reinstrup Bihlet, Yves Henrotin, Edith Ming Chu Lau, et al.
Arthritis Research & Therapy
|
September 5, 2019
Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis
Asger Reinstrup Bihlet, Inger Byrjalsen, Anne-Christine Bay-Jensen, et al.
Seminars in Arthritis and Rheumatism
|
March 22, 2021
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial
Hans Guehring, Flavie Moreau, Benjamin Daelken, et al.
Seminars in Arthritis and Rheumatism
|
May 19, 2021
Response letter to the Editor
Philip G Conaghan, Hans Guehring, Flavie Moreau, et al.
Osteoarthritis and Cartilage
|
November 9, 2025
The impact of screening period pain inconsistency on placebo response in intra-articular knee osteoarthritis trials
Jakob Mejdahl Bentin, Ida Sofie Adrian, Alejandro Castillo Mondragon, et al.
Frontiers in Pharmacology
|
November 8, 2021
The Efficacy and Safety of Multiple Dose Regimens of Kudzu (<i>Pueraria lobata</i>) Root Extract on Bone and Cartilage Turnover and Menopausal Symptoms
Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, et al.
JAMA
|
October 9, 2019
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial
Marc C Hochberg, Ali Guermazi, Hans Guehring, et al.
BMC Musculoskeletal Disorders
|
January 19, 2018
Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis
Asger Reinstrup Bihlet, Inger Byrjalsen, Anne-Christine Bay-Jensen, et al.
ACR Open Rheumatology
|
February 4, 2024
Safety, Tolerability, and Pharmacodynamics of the ADAMTS-5 Nanobody M6495: Two Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies in Healthy Subjects and Patients With Osteoarthritis
Asger Reinstrup Bihlet, Torben Balchen, Kosalaram Goteti, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 24) with videos related to
Sort By:
Page
of 3
Osteoarthritis and Cartilage
|
June 6, 2024
Is detection of disease-modifying osteoarthritis drug treatment more effective when performing cartilage morphometry without blinding to MR image acquisition order?
Felix Eckstein, Anna Wisser, Susanne Maschek, et al.
Osteoarthritis and Cartilage
|
September 27, 2025
A single intra-articular injection of JTA-004, a combination of human plasma, hyaluronic acid, and clonidine, versus placebo in symptomatic knee osteoarthritis: A Phase 3 trial
Asger Reinstrup Bihlet, Yves Henrotin, Edith Ming Chu Lau, et al.
Arthritis Research & Therapy
|
September 5, 2019
Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis
Asger Reinstrup Bihlet, Inger Byrjalsen, Anne-Christine Bay-Jensen, et al.
Seminars in Arthritis and Rheumatism
|
March 22, 2021
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial
Hans Guehring, Flavie Moreau, Benjamin Daelken, et al.
Seminars in Arthritis and Rheumatism
|
May 19, 2021
Response letter to the Editor
Philip G Conaghan, Hans Guehring, Flavie Moreau, et al.
Osteoarthritis and Cartilage
|
November 9, 2025
The impact of screening period pain inconsistency on placebo response in intra-articular knee osteoarthritis trials
Jakob Mejdahl Bentin, Ida Sofie Adrian, Alejandro Castillo Mondragon, et al.
Frontiers in Pharmacology
|
November 8, 2021
The Efficacy and Safety of Multiple Dose Regimens of Kudzu (<i>Pueraria lobata</i>) Root Extract on Bone and Cartilage Turnover and Menopausal Symptoms
Asger Reinstrup Bihlet, Inger Byrjalsen, Jeppe Ragnar Andersen, et al.
JAMA
|
October 9, 2019
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial
Marc C Hochberg, Ali Guermazi, Hans Guehring, et al.
BMC Musculoskeletal Disorders
|
January 19, 2018
Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis
Asger Reinstrup Bihlet, Inger Byrjalsen, Anne-Christine Bay-Jensen, et al.
ACR Open Rheumatology
|
February 4, 2024
Safety, Tolerability, and Pharmacodynamics of the ADAMTS-5 Nanobody M6495: Two Phase 1, Single-Center, Double-Blind, Randomized, Placebo-Controlled Studies in Healthy Subjects and Patients With Osteoarthritis
Asger Reinstrup Bihlet, Torben Balchen, Kosalaram Goteti, et al.
Page
of 3